SUMMARY Morning hyperglycaemia remains a challenge to conventional insulin regimens. Eighteen adolescents participated in a one year crossover study to examine the effect of delaying the evening intermediate acting insulin from before the evening meal to bedtime. This three injection regimen caused slightly higher blood glucose concentrations in the early part of the night, and lower concentrations in the morning, but no overall change in glycosylated haemoglobin concentrations (HbA1I). Seasonal change accounted for substantially more of the variance in HbA1I concentrations than did the regimen change. The three injection regimen did not alter the frequency of hypoglycaemic episodes.
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Metabolic control on both regimens might have been improved by more intensive monitoring and medical attention. This study suggests that factors beyond medical control, such as seasonal variation, may contribute more to the control of diabetes in adolescents than changes in conventional insulin regimens, particularly when unaccompanied by intensive monitoring.
The classic primary aims of treatment for the child with insulin dependent diabetes are to maintain normal growth and development while preventing symptomatic hypo-or hyperglycaemia.' As the evidence relating glycaemic control to microvascular complications has increased,2 so the emphasis of management has been extended towards achieving normoglycaemia. 3 One of the major barriers to glycaemic control on conventional insulin regimens is the dawn phenomenon. This consists of a rise in blood glucose concentrations that starts in the early hours of the morning and continues after breakfast, causing a mid-morning glycaemic peak. 4 Although the dawn phenomenon has been shown to be largely due to the glycaemic effects of nocturnal secretion of growth hormone,5 it is likely to be exacerbated by the failure of conventional insulin regimens to maintain insulin concentrations throughout the night. Attempts to prevent morning hyperglycaemia by increasing the evening insulin dose may result in nocturnal hypoglycaemia, and the ensuing 'Somogyi effect' will further compromise blood glucose control.6 Nocturnal hypoglycaemia thus limits the effectiveness of twice daily insulin regimens in controlling the dawn phenomenon.
Delaying the intermediate acting portion of the evening insulin injection from before the evening meal until bedtime has been shown to improve morning blood glucose concentrations, without increasing nocturnal hypoglycaemia, in adult patients selected because they showed a noticeable dawn phenomenon.7 The incidence and severity of this phenomenon in childhood are not known. We have therefore performed a one year crossover study comparing the classic twice daily 'mixed' injection with a three injection regimen involving a split evening injection. The study was performed on adolescent patients because we hoped that this older age group would be more tolerant of the third injection; the notorious poor control at this time also suggested significant possible benefits.8 Children were not selected on the grounds of glycaemic control, as we wished to establish the value of this regimen, and thus the importance of the dawn phenomenon, to the 'average' adolescent patient.
Methods
Patients. Nineteen patients were selected from the population attending the Nottingham Children's Diabetic Clinic on the grounds of age (adolescent) and duration of diabetes (>2 years) (Table 1) . All children and their parents gave informed consent to the trial, which had the approval of the local ethical committee. One girl failed to comply with the trial protocol and was, therefore, excluded. Results presented are from the 18 patients who completed the trial, none of whom suffered any other major illness during the study period. 118 (12-4%) was slightly higher than the clinic age group mean (11.8%). At entry to the study all children were being treated with injections of mixed intermediate and short acting highly purified porcine insulin, given before breakfast and before the main evening meal-a two injection regimen.
Procedure. After a four month run in period the children were randomly allocated to two groups. One group continued the two injection regimen. The other group received the trial three injection regimen: a normal 'mixed' morning injection, an injection of short acting insulin only given before the main evening meal, and an injection of intermediate acting insulin shortly before bed. After four months the children were switched over to the alternative regimen for the final four months of the study. The last child to be randomised entered and completed the study 11 weeks after the first. The total daily insulin dose, as well as the proportions taken as morning or evening, short or intermediate, acting insulin were similar on both regimens (Table 2) . Table 2 Anthropometry, hypoglycaemia, and insulin dose in the patients when given two or three injections. group.bmj.com on June 9, 2017 -Published by http://adc.bmj.com/ Downloaded from Children were seen at monthly intervals throughout the study, clinic attendances taking place at randomisation and at the end of both study periods. All other consultations took place in the children's homes. During the run in period efforts were made to improve metabolic control, with particular emphasis on reducing morning hyperglycaemia while attempting to avoid nocturnal hypoglycaemia.
Monitoring. At each consultation details of insulin dosage, diabetic symptoms, and intercurrent illnesses were recorded, and a capillary blood specimen obtained for estimation of HbAj, concentrations.
Children were asked to provide a four point blood glucose series (three pre prandial and one bedtime measurement) twice weekly, with midnight and 0300 measurements twice a month. Two methods of home blood glucose measurement were used: five patients used Dextrostix (Ames) read with Glucochek meters (Medistron Limited); the remainder used visually read BM 20/800 sticks (BoehringerMannheim). The method of measurement remained constant for each child throughouit the study. During the three days before each consultation children used Sarstedt fluoride capillary tubes to provide one eight point blood glucose series (before and after the three main meals, midnight, and 0300), and two additional fasting specimens. These tubes were stored at roughly 4°C until laboratory blood glucose analysis not more than four days later.
Height and weight were measured at each clinic visit, and a post prandial specimen of blood obtained on one occasion for C peptide assay and routine biochemistry. Questionnaire. At the end of the study all patients completed a questionnaire comparing the two regimens. On a five point scale they indicated which regimen they considered had given best blood glucose control, made them feel generally better, caused more problems with hypoglycaemia, was more convenient, and which they would prefer to continue with.
Results
Blood glucose. During the two treatment periods children performed 85% of requested home and 88% of requested laboratory blood glucose measurements. Friedman two way analysis of variance showed that no consistent changes in blood glucose profiles took place within the period of either treatment regimen. The values at individual time points did not conform to a normal distribution, and the results were therefore assessed using the median values of each child's blood glucose concentrations at each time point. Comparisons between the regimens were made using Wilcoxon's matched pairs signed ranks test.
Both the home and laboratory blood glucose measurements showed only small differences between the regimens. The laboratory measurements (Fig. 1) showed that blood glucose concentrations were lower before breakfast on the three injection regimen (p=0-03). The Hypoglycaemic episodes. (Table 2 ). These were recorded as: mild=mild symptoms rapidly relieved; moderate=made the child unwell, caused an upset to family routine; and severe=requiring admission to hospital, intravenous glucose, or glucagon. There was no difference between the regimens in any category of hypoglycaemia. Eight children experienced symptomatic nocturnal hypoglycaemia during the whole study; these episodes were slightly more common on two injections than three. Unrecognised nocturnal hypoglycaemia, defined as a home measured blood glucose concentration of less than 4-0 mmol/l (72 mg/100 ml), or a laboratory measured concentration of less than 3-5 mmol/I (63 mg/100 ml), occurred with equal frequency on both regimens. This occurred on about 10% of nights tested and affected all but two of the children during the year of the study. (Fig. 2) , the most prominent feature of which was a fall in mean concentrations during spring and early summer.
Anthropometry (
The seasonal variation was examined further with multiple regression analysis. This method was used in order to eliminate any effect of disproportionate patient representation in the monthly summaries.
All HbAl, concentrations from the whole study, including the run in period, were entered, together with identifiers of the child, month of sampling, and the regimen. 'Regimen' had three values: the run in and both treatment periods. This showed that 60% of the variation in HbAl, concentrations was accounted for by the differences between individual children (p<0.001). The addition of 'regimen' to the equation accounted for a further 0-4% of the variance (p=NS), while the addition of 'month' to 'child' accounted for a further 3-6% (p<0-01).
There was a small interaction between month and regimen. It can, therefore, be seen that 'month' was a substantially more important predictor of HbAl, concentrations than the differences between the insulin regimens.
Questionnaire. In terms of blood glucose control, nine children preferred three injections, while four preferred two injections. A small majority (seven v five) had felt generally better on the trial regimen.
Five children reported more problems with hypoglycaemia on three injections compared with two children on two injections. Thirteen (v two) found two injections more convenient and 11 (v five) opted to continue with this regimen.
Discussion
The options for improving nocturnal control on conventional insulin regimens include delaying the second injection of the day, introducing a third injection, or using an alternative delayed release preparation.1' In a previous study, performed on younger children, we found that delaying the second injection of the day until bedtime caused some improvement in morning blood glucose concentrations but higher concentrations in the evening. '2 This suggested possible benefits from the addition of a third injection before the evening meal. This second strategy, of splitting the evening injection, has been used on adults selected on grounds of excess morning glycaemia.7
Nine of the 16 children who provided midmorning blood glucose concentrations had their highest concentration of the day at this time. This figure is not quite as high as the incidence of 84% quoted for adult patients'3 but, together with examination of the overall blood glucose profiles, suggests that the dawn phenomenon is a frequent and significant finding in this age group. 
